Xencor (XNCR) FCF Margin Growth (5y) (2018 - 2026)
Xencor (XNCR) FCF Margin Growth (5y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Xencor | 1.47 Bn | 1.09 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -141,715.00 |
| Dec 31, 2025 | -22,046.00 |
| Sep 30, 2025 | -12,344.00 |
| Jun 30, 2025 | 13,196.00 |
| Mar 31, 2025 | -7,678.00 |
| Dec 31, 2024 | 54,201.00 |
| Sep 30, 2024 | -12,370.00 |
| Jun 30, 2024 | -84,713.00 |
| Mar 31, 2024 | -33,916.00 |
| Dec 31, 2023 | 20,291.00 |
| Sep 30, 2023 | -1,188.00 |
| Dec 31, 2022 | -14,924.00 |
| Sep 30, 2022 | 2,995.00 |
| Jun 30, 2022 | 21,478.00 |
| Mar 31, 2022 | 31,979.00 |
| Dec 31, 2021 | 9,128.00 |
| Sep 30, 2021 | -191,702.00 |
| Jun 30, 2021 | 6,677.00 |
| Mar 31, 2021 | 10,768.00 |
| Dec 31, 2020 | 4,306.00 |